Schonfeld Strategic Advisors LLC Concert Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $1.06 Million - $1.43 Million	244,574 Added 94.39%	503,674 $2.94 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $851,864 - $1.44 Million	199,500 Added 334.73%	259,100 $1.74 Million
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $166,880 - $379,056	59,600 New	59,600 $251,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $589,056 - $818,688	-62,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $753,168 - $1.09 Million	62,400 New	62,400 $754,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.